Falvin 2% vaginal cream with applicator - candida treatment 78 g

Product Description

Recordati

Vaginal cream

Falvin 2% vaginal cream, Falvin 200 mg and 600 mg vaginal soft capsules, Falvin 0.2% vaginal solution: Candidiasis of the genital mucosa (vulvovaginitis, colpitis, infectious fluoride). Falvin 1000 mg vaginal soft capsules: Vaginal trichomoniasis. Vaginal infections caused in mixed form by Trichomonas vaginalis and Candida albicans. Candidiasis of the genital mucosa (vulvovaginitis, colpitis, infectious fluoride).

Technical data sheet (SmPC) Excipients:

The fatty excipients and oils contained in the vaginal soft capsules or vaginal cream may damage latex contraceptives (see section 4.4).

Technical data sheet (SmPC) Composition:

Falvin 2% vaginal cream 100 g of vaginal cream contain 2 g of fenticonazole nitrate. Excipients with known effect: 100 g of vaginal cream contain 5 g of propylene glycol, 3 g of cetyl alcohol, 1 g of hydrogenated lanolin. Falvin 200 mg vaginal soft capsules Each vaginal soft capsule contains 200 mg of fenticonazole nitrate. Excipients with known effect: Each vaginal soft capsule contains 0.80 mg sodium ethyl parahydroxybenzoate, 0.40 mg sodium propyl parahydroxybenzoate.Falvin 600 mg vaginal soft capsulesEach vaginal soft capsule contains 600 mg fenticonazole nitrate. Excipients with known effect: Each vaginal soft capsule contains 1 mg sodium ethyl parahydroxybenzoate, 0.50 mg sodium propyl parahydroxybenzoate. Falvin 1000 mg vaginal soft capsulesEach vaginal soft capsule contains 1000 mg fenticonazole nitrate. Excipients with known effect: Each vaginal soft capsule contains 1.60 mg of sodium ethyl parahydroxybenzoate, 0.70 mg of sodium propyl parahydroxybenzoate.Falvin 0.2% vaginal solution100 ml of vaginal solution contains 0.2 g of fenticonazole nitrate. Excipients with known effect: 100 ml of vaginal solution contains 10 g of propylene glycol, 0.01 g of benzalkonium chloride. For a full list of excipients, see section 6.1.